Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2
Publication
, Journal Article
Luedke, C; Rein, L
Published in: Blood
August 27, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
August 27, 2020
Volume
136
Issue
9
Start / End Page
1113 / 1113
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Luedke, C., & Rein, L. (2020). Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2. Blood, 136(9), 1113–1113. https://doi.org/10.1182/blood.2019004410
Luedke, Catherine, and Lindsay Rein. “Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2.” Blood 136, no. 9 (August 27, 2020): 1113–1113. https://doi.org/10.1182/blood.2019004410.
Luedke C, Rein L. Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2. Blood. 2020 Aug 27;136(9):1113–1113.
Luedke, Catherine, and Lindsay Rein. “Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2.” Blood, vol. 136, no. 9, American Society of Hematology, Aug. 2020, pp. 1113–1113. Crossref, doi:10.1182/blood.2019004410.
Luedke C, Rein L. Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2. Blood. American Society of Hematology; 2020 Aug 27;136(9):1113–1113.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
August 27, 2020
Volume
136
Issue
9
Start / End Page
1113 / 1113
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology